BIOCON
|
The Current P/S Ratio of BIOCON is 3.64.
| Share Price | ₹377.8 | Mar 17,2026 |
| Market Cap | ₹61,237.6 Cr | |
| Sales-TTM | ₹16,827.4 Cr | TTM-Consolidated Results |
| Price/Sales | 3.64x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BIOCON
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹61,237.6 Cr] as on Mar 17,2026
(/) Sales [ ₹16,827.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.64x ]
Thus, for BIOCON , the investors are currently willing to pay '3.64 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BIOCON !
The chart below summarizes the trend in P/S Ratio of BIOCON over the last five years.
Historical PS (Price/Sales) ratio chart of BIOCON
PS Ratio Performance Analysis for BIOCON
- BIOCON 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.77x.
- BIOCON 's operated at median p/e ratio of 2.68x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/e ratio peaked in Mar2021 at 6.87x.
- BIOCON 's p/e ratio hit its five-year low in Mar2024 of 2.15x.
How does BIOCON 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BIOCON | 16,827.4 | 3.64 | 61,237.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.58 | 430,825.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.66 | 161,535.0 |
| CIPLA LTD | 28,351.1 | 3.65 | 103,513.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.44 | 145,733.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.09 | 107,094.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.13 | 85,350.2 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.43 | 89,544.8 |
| LUPIN LTD | 26,150.5 | 4.02 | 105,040.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.25 | 74,772.4 |
| ABBOTT INDIA LTD | 6,824.1 | 8.24 | 56,235.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BIOCON 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.25x |
| Max industry PS | 15.66x |
| Median industry PS | 4.02x |
| Average industry PS | 6.29x |
You may also like the below Video Courses